"Very expensive, very effective" cancer drug has Stottlemyre back in baseball with M's Print
Written by Admin   
Tuesday, 23 October 2007 10:30
MLB Headline News

 SEATTLE (AP) -Mel Stottlemyre was getting his white blood cells counted for yet another month. Unsolicited, his doctor said he could go back to full-time work again, back to the ballpark routine he had followed just about every summer for 41 years.
Then came another unexpected offer.
Stottlemyre returned to the major leagues this week as the pitching coach of the Seattle Mariners, accepting the first of what he hopes is a series of one-year contracts. It's the only job that could get him back into a dugout.
``I certainly hope it lasts for more than one year,'' Stottlemyre said. ``Whatever happens, at my age and certainly with my health issue, I'm excited for the opportunity.''
cycle he takes to combat multiple myeloma.
But this time, she surprised the old right-hander-turned-fisherman.
``You have no restrictions to go back to work full time, if you want,'' she told him a few months ago.
``I wasn't even looking for that,'' Stottlemyre said Monday night.
The former five-time All-Star with the Yankees left them in 2005, after 10 seasons and four World Series titles as New York's pitching coach. He said he was tired of criticism from owner George Steinbrenner. Born in Yakima, Wash., he returned to his home in the Seattle suburb of Issaquah and interviewed that fall to become manager Mike Hargrove's pitching coach with the Mariners. Hargrove chose relatively inexperienced Rafael Chaves instead.
Stottlemyre dabbled in spring training and instructional league work with the Arizona Diamondbacks last year. He golfed, fished and helped his son Todd, one of two sons who also pitched in the majors, begin his new career as a financial adviser.
One of the first clients he lined up for Todd was John McLaren, the Mariners bench coach who became manager when Hargrove abruptly resigned July 1.
The dividends from that arrangement arrived this month. McLaren called to ask Stottlemyre to replace Chaves, after Seattle's starters had a 5.12 ERA this past season - 12th in the AL. They were the main reason for the remarkable September collapse that doomed Seattle's unlikely contention for a playoff spot.
``Mel was my No. 1 choice,'' McLaren said. ``His reputation speaks for itself.''
Stottlemyre was content fishing, golfing and staving off cancer.
``I wasn't really anxious to get back into the game - until the Seattle job came open,'' Stottlemyre said. ``I've always wondered what it would be like to be in baseball but still be able to come home every day.''
McLaren had been golfing with Stottlemyre over the last year and noticed that his friend's health was not an issue.
``I sure wouldn't want to mess with Mel. He's strong as a horse,'' McLaren said.
Stottlemyre credits the cancer drug lenalidomide, marketed under the brand name Revlimid, for repelling his disease. Revlimid isn't for everyone. Its retail price can reach $6,400 a month, according to the Center for Medicine in the Public Interest.
``It's very expensive, but it's very effective,'' Stottlemyre said. ``With the type of cancer I've had it's something where they never use the word 'cure.' Right now, it's not curable. It's treatable.
``I'm doing absolutely super. I have no signs of the disease. I wouldn't call it a 'remission' so much as I would say that I'm on a tremendous maintenance program.''
Stottlemyre will have a far different pitching staff than the one he enjoyed with the Yankees. Instead of tutoring the likes of Roger Clemens, Mike Mussina and Andy Pettitte, he'll be demanding that Seattle's 21-year-old ace Felix Hernandez plus veteran holdovers Jarrod Washburn and Miguel Batista pitch inside more - something Stottlemyre focuses on. He also will advise McLaren and general manager Bill Bavasi as they seek another veteran starter this winter.
``At first glance, I see a very challenging job,'' Stottlemyre said of his new group of pitchers. ``I hope that I have something to add to each that will help each one.''
 

MLB Team Pages

Top MLB Public Bets

#1 964 Oakland Athletics 80%
#2 958 Milwaukee Brewers 78%
#3 954 Atlanta Braves 75%
#4 962 New York Yankees 71%
#5 960 Toronto Blue Jays 67%
#6 972 Seattle Mariners 67%
#7 952 Philadelphia Phillies 63%
#8 970 Los Angeles Angels 63%
#9 955 San Diego Padres 56%
#10 967 Chicago White Sox 54%
View All: NFL |  NBA |  NCAAF |  NCAAB |  MLB |  NHL

MLB Futures

MLB TEAM WORLD SERIES ODDS CURRENT
OAKLAND ATHLETICS 5/1
LOS ANGELES DODGERS 6/1
DETROIT TIGERS 6/1
LOS ANGELES ANGELS 9/1
WASHINGTON NATIONALS 10/1
ST LOUIS CARDINALS 10/1
SAN FRANCISCO GIANTS 12/1
ATLANTA BRAVES 14/1
BALTIMORE ORIOLES 14/1
MILWAUKEE BREWERS 16/1
View All

Privacy Policy | Terms of Service | Contact Us | Advertising | 888-99-SPREAD

THIS IS NOT A GAMBLING SITE – If you think you have a gambling problem click here.

Disclaimer: This site is for informational and entertainment purposes only. Individual users are responsible for the laws regarding accessing gambling information from their jurisdictions. Many countries around the world prohibit gambling, please check the laws in your location. Any use of this information that may violate any federal, state, local or international law is strictly prohibited.

Copyright: The information contained on TheSpread.com website is protected by international copyright and may not be reproduced, or redistributed in any way without expressed written consent.

About: TheSpread.com is the largest sports betting news site in the United States. We provide point spread news, odds, statistics and information to over 199 countries around the world each year. Our coverage includes all North American College and Professional Sports as well as entertainment, political and proposition wagering news.

©1999-2013 TheSpread.com